Smith Jason Drew
General Counsel at URGN
- Sold, on record
- $725k
- Dollars the filings state
- Form 4 sales
- 12
- Latest Sep 8, 2026
- Form 144 notices
- 3
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- URGNUroGen Pharma Ltd.General Counsel
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale URGNNo planSep 9, 2024 2024
Sold 1,521 shares at $13.08 ($20k)
Smith Jason Drew, General Counsel
No 10b5-1 planSold 5.7% of holdings ($350k position)25,226 shares left0.4x usual sizeFiling
- 2 Form 4 sale URGNNo planJan 31, 2025 +144 days
Sold 7,379 shares at $11.14 ($82k)
Smith Jason Drew, General Counsel
No 10b5-1 planSold 18.5% of holdings ($444k position)32,514 shares left1.9x usual sizeFiling
- 3 Form 144 notice URGNNoticeJul 28, 2025 +178 days
Filed to sell 7,522 shares ($143k)
Smith Jason Drew, Officer
No 10b5-1 plan1.7x usual sizeFiling
- 4 Form 4 sale URGNNo planJul 28, 2025 same day
Sold 7,522 shares at $19.14 ($144k)
Smith Jason Drew, General Counsel
No 10b5-1 planSold 15.3% of holdings ($938k position)41,492 shares left1.7x usual sizeFollows a Form 144Filing
- 5 Form 144 notice URGNNoticeSep 8, 2025 +42 days
Filed to sell 1,520 shares ($29k)
Smith Jason Drew, Officer
No 10b5-1 plan0.2x usual sizeFiling
- 6 Form 4 sale URGNNo planSep 8, 2025 same day
Sold 1,520 shares at $19.11 ($29k)
Smith Jason Drew, General Counsel
No 10b5-1 planSold 3.4% of holdings ($857k position)43,305 shares left0.2x usual sizeFollows a Form 144Filing
- 7 Form 4 sale URGNNo planFeb 3, 2026 +148 days
Sold 7,479 shares at $19.69 ($147k)
Smith Jason Drew, General Counsel
No 10b5-1 planSold 11.9% of holdings ($1.2M position)55,588 shares left1.7x usual sizeFiling
- 8 Form 4 sale URGNNo planSep 8, 2026 +217 days
Sold 1,519 shares at $42.54 ($65k)
Smith Jason Drew, General Counsel
No 10b5-1 planSold 2.8% of holdings ($2.3M position)53,141 shares left0.2x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (15)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | Sep 9, 2026 | URGN | General Counsel | Form 4 sale | 1,519 | $65k | 2.8% | No plan | SEC |
| Feb 3, 2026 | Feb 11, 2026 | URGN | General Counsel | Form 4 sale | 7,479 | $147k | 11.9% | No plan | SEC |
| Sep 8, 2025 | Sep 9, 2025 | URGN | General Counsel | Form 4 sale | 1,520 | $29k | 3.4% | No plan | SEC |
| Sep 8, 2025 | Sep 9, 2025 | URGN | Officer | Form 144 notice | 1,520 | $29k | Notice | SEC | |
| Jul 28, 2025 | Jul 30, 2025 | URGN | General Counsel | Form 4 sale | 7,522 | $144k | 15.3% | No plan | SEC |
| Jul 28, 2025 | Jul 29, 2025 | URGN | Officer | Form 144 notice | 7,522 | $143k | Notice | SEC | |
| Jan 31, 2025 | Feb 4, 2025 | URGN | General Counsel | Form 4 sale | 7,379 | $82k | 18.5% | No plan | SEC |
| Sep 9, 2024 | Sep 12, 2024 | URGN | General Counsel | Form 4 sale | 1,521 | $20k | 5.7% | No plan | SEC |
| Jan 31, 2024 | Feb 2, 2024 | URGN | General Counsel | Form 4 sale | 4,993 | $79k | 17.6% | No plan | SEC |
| Jan 31, 2024 | Feb 1, 2024 | URGN | Officer | Form 144 notice | 4,993 | $79k | Notice | SEC | |
| Aug 31, 2023 | Sep 5, 2023 | URGN | General Counsel | Form 4 sale | 3,800 | $68k | 17.1% | No plan | SEC |
| Jan 31, 2023 | Feb 2, 2023 | URGN | General Counsel | Form 4 sale | 1,636 | $17k | 10.5% | Plan not stated | SEC |
| Aug 31, 2022 | Sep 2, 2022 | URGN | General Counsel | Form 4 sale | 3,606 | $26k | 22.8% | Plan not stated | SEC |
| Jan 31, 2022 | Feb 2, 2022 | URGN | General Counsel | Form 4 sale | 414 | $3k | 5.3% | Plan not stated | SEC |
| Nov 30, 2021 | Dec 2, 2021 | URGN | General Counsel | Form 4 sale | 3,803 | $46k | 35.1% | Unusual | SEC |